Clinical Trial Update: Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine, cisplatin, and celecoxib for metastatic pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Celecoxib (Celecoxib)
• Gemzar (gemcitabine)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED